Exercise and Dry Needling Treatment Combination in Nocturnal Calf Cramps
The Effectiveness of Exercise and Dry Needling Treatment Combination in Patients With Nocturnal Calf Cramps
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Kars, Turkey
- Kars State Hospital
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patients with only nocturnal calf cramp
- Patients with a trigger point in the unilateral gastrocnemius muscle
- Being between the ages of 18-50
Exclusion Criteria:
- Patients using diuretics or hypertension medications that may trigger cramping
- Those with a chronic disease history
- Those diagnosed with spinal stenosis
- Electrolyte disturbance in laboratory tests
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Exercise Group
It describes the exercise protocol that the patients will do.
|
Stretching exercise: Stretching exercises were planned for 30 seconds, ten repetitions for each stretching, 10 minutes in total, four days a week, for two weeks.
|
|
Experimental: Exercise plus Dry Needling Group
It describes the exercise protocol to be performed by the patients and the methodology of dry needling to be applied.
|
Stretching exercise: Stretching exercises were planned for 30 seconds, ten repetitions for each stretching, 10 minutes in total, four days a week, for two weeks.
Dry needling: A total of 3 sessions of dry needling, once a week, were applied to the gastrocnemius muscle.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in calf cramp duration
Time Frame: 3 months
|
How many seconds the patient feels cramp is questioned.
Higher values represent a worse outcome
|
3 months
|
|
Change in Number of Cramps
Time Frame: 3 months
|
How many times a day the patient feels cramp is recorded.
Higher values represent a worse outcome
|
3 months
|
|
Change in cramp intensity levels with visual analog scale
Time Frame: 3 months
|
How intense the cramp felt by the patient was recorded with a visual analog scale.
The score is between 0 to 10, and higher values represent a worse outcome.
|
3 months
|
|
Change in algometric sensitivity measurement
Time Frame: 3 months
|
Myofascial trigger point sensitivity in the gastrocnemius muscle was measured with an algometer.
Higher scores represent a worse outcome.
|
3 months
|
|
Change in sleep quality
Time Frame: 3 months
|
The sleep quality of the patients was evaluated with the Pittsburgh Sleep Quality index.
The global PSQI score is then calculated by totaling the seven component scores, providing an overall score ranging from 0 to 21, where lower scores denote a healthier sleep quality.
|
3 months
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Fatih Bagcier, M.D., Kars State Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Mental Disorders
- Nervous System Diseases
- Sleep Wake Disorders
- Neurologic Manifestations
- Musculoskeletal Diseases
- Rheumatic Diseases
- Muscular Diseases
- Neuromuscular Diseases
- Neuromuscular Manifestations
- Parasomnias
- Fibromyalgia
- Myofascial Pain Syndromes
- Spasm
- Muscle Cramp
- Sleep-Wake Transition Disorders
Other Study ID Numbers
Other Study ID Numbers
- Biruni University
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.